Q4 2024 Gland Pharma Ltd Earnings Call Transcript
Ladies and gentlemen, good day, and welcome to Gland Pharma Limited Q4 and FY24 earnings conference call. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Mr. Ankit. Thank you and over to you, sir.
Thank you, Nirap. Good evening, everyone, and we welcome you to Gland Pharma earnings conference call for Q4 and FY24. My name is Ankit and I head Investment, M&A, and Corporate Strategy at Gland. Joining me today are Mr. Srinivas Sadu, our MD and CEO; Mr. Ravi Mitra, our CFO; and we also have today Mr. Alain, the CEO of Cenexi, our European CDMO business. Together today, we'll discuss our business performance and address any questions that you may have.
We will begin with the business highlights on Gland and Cenexi from Mr. Sadu, followed by an overview on Cenexi and the turnaround strategy from Mr. Alain, and lastly, the group financial review by Mr. Ravi. Before we proceed, I'd like to remind everyone that some of the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
